Add like
Add dislike
Add to saved papers

Pyridinic-N Protected Synthesis of 3D Nitrogen-Doped Porous Carbon with Increased Mesoporous Defects for Oxygen Reduction.

Small 2019 Februrary 9
Nitrogen (N)-doped carbons are potential nonprecious metal catalysts to replace Pt for the oxygen reduction reaction (ORR). Pyridinic-N-C is believed to be the most active N group for catalyzing ORR. In this work, using zinc phthalocyanine as a precursor effectively overcomes the serious loss of pyridinic-N, which is commonly regarded as the biggest obstacle to catalytic performance enhancement upon adopting a second pyrolysis process, for the preparation of a 3D porous N-doped carbon framework (NDCF). The results show only ≈14% loss in pyridinic-N proportion in the Zn-containing sample during the second pyrolysis process. In comparison, a loss of ≈72% pyridinic-N occurs for the non-Zn counterpart. The high pyridinic-N proportion, the porous carbon framework produced upon NaCl removal, and the increased mesoporous defects in the second pyrolysis process make the as-prepared catalyst an excellent electrocatalyst for ORR, exhibiting a half-wave potential (E1/2 = 0.88 V) up to 33 mV superior to state-of-the-art Pt/C and high four-electron selectivity (n > 3.83) in alkaline solution, which is among the best ORR activities reported for N-doped carbon catalysts. Furthermore, only ≈18 mV degradation in E1/2 occurs after an 8000 cycles' accelerating stability test, manifesting the outstanding stability of the as-prepared catalyst.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app